Congenital myopathies
Congenital myopathies
复制标题
DOI:
10.1097/wco.0b013e3282ef6e69
复制
发表时间:
2007-10-01
影响因子:
4.8
通讯作者:
Laing, Nigel G.
中科院分区:
文献类型:
--
作者:
Laing, Nigel G.
Purpose of reviewThe aim of this review is to provide an up-to-date personal analysis of current congenital myopathy research.Recent findingsIn the past year novel congenital myopathies have been suggested, genes have been discovered for some of the congenital myopathies for the first time (P-tropomyosin in cap disease and perhaps skeletal muscle a-actin in Zebra body myopathy), further genes have been identified for congenital myopathies where other genes had already been found (cofilin in nemaline myopathy, selenoprotein N in congenital fibre type disproportion) and recessive myosin storage myopathy was associated with homozygous mutation of slow-skeletal/beta-cardiac myosin which was already known to be mutated in dominant myosin storage myopathy. There has been further clarification of the pathobiology of the congenital myopathies, including determination of the basis of epigenetic effects: silencing of the normal allele in recessive central core disease and persistence of cardiac (fetal) a-actin in nemaline myopathy patients with no skeletal actin.SummaryThe increased understanding of the genes and pathobiology of the congenital myopathies that is developing should ultimately lead to effective treatments.